(Q57763211)

17

object named as

Namiki Izumi

0 references

author name string

Haruhiko Yoshida

1

0 references

Yasushi Shiratori

2

0 references

Shuichiro Shiina

4

0 references

Toshihiko Mizuta

5

0 references

Masamichi Kojiro

6

0 references

Kyosuke Yamamoto

7

0 references

Yukihiro Koike

8

0 references

Kenichi Saito

9

0 references

Nozomu Koyanagi

10

0 references

Takao Kawabe

11

0 references

Seiji Kawazoe

12

0 references

Haruhiko Kobashi

13

0 references

Hiroshi Kasugai

14

0 references

Yukio Osaki

15

0 references

Yasuyuki Araki

16

0 references

Hiroko Oka

18

0 references

Kunihiko Tsuji

19

0 references

Joji Toyota

20

0 references

Toshihito Seki

21

0 references

Toshiya Osawa

22

0 references

Naohiko Masaki

23

0 references

Masao Ichinose

24

0 references

Masataka Seike

25

0 references

Akihisa Ishikawa

26

0 references

Yoshiyuki Ueno

27

0 references

Kazumi Tagawa

28

0 references

Ryoko Kuromatsu

29

0 references

Shotaro Sakisaka

30

0 references

Hiroshi Ikeda

31

0 references

Hidekatsu Kuroda

32

0 references

Hiroyuki Kokuryu

33

0 references

Tatsuya Yamashita

34

0 references

Isao Sakaida

35

0 references

Tetsuo Katamoto

36

0 references

Kentaro Kikuchi

37

0 references

Minoru Nomoto

38

0 references

Masao Omata

Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence

39

0 references

language of work or name

English

0 references

publication date

26 June 2011

0 references

published in

Hepatology

0 references

volume

54

0 references

issue

2

0 references

page(s)

532-540

0 references

cites work

1 reference

Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves

21 January 2018

1 reference

Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver

21 January 2018

1 reference

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

21 January 2018

1 reference

Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: Inhibitory actions of vitamin K

21 January 2018

1 reference

Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation

21 January 2018

1 reference

Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation

21 January 2018

1 reference

Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43.

21 January 2018

1 reference

Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines

21 January 2018

1 reference

Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis

21 January 2018

1 reference

Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women

21 January 2018

1 reference

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

21 January 2018

1 reference

Modification of sample size in group sequential clinical trials

21 January 2018

1 reference

Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection

21 January 2018

1 reference

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes

21 January 2018

1 reference

7 January 2021

Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma

1 reference

7 January 2021

Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers

1 reference

7 January 2021

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

7 January 2021

Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial

1 reference

7 January 2021

Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody

1 reference

7 January 2021

Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules

1 reference

7 January 2021

The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study

1 reference

7 January 2021

Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas

1 reference

7 January 2021